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㩷 1) Kim H.Y., Oi Y., Kim M., and Yokozawa T.: Protective Effect of Lipoic Acid against 
Methylglyoxal-Induced Oxidative Stress in LLC-PK1 Cells. J. Nutr. Sci. Vitaminol., 54: 
99-104, 2008. 
㩷 Abstract㪑 Methylglyoxal (MG), a reactive dicarbonyl compound, is a metabolic byproduct of glycolysis 
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often found at high levels in blood from diabetic patients. The effect of lipoic acid on MG-induced 
oxidative stress was investigated using LLC-PK1 renal tubular epithelial cells, which are susceptible to 
oxidative stress. MG (500 microM) treatment induced LLC-PK1 cell death to nearly 50% compared with 
non-treated control cells, but lipoic acid significantly inhibited the MG-induced cytotoxicity in a 
concentration-dependent manner. In addition, lipoic acid treatment dose-dependently reduced the 
intracellular reactive oxygen species level increased by 500 microM MG. The nitric oxide level was also 
increased by 500 microM MG treatment, but it was significantly inhibited by lipoic acid. Furthermore, 
lipoic acid treatment at 50 microM inhibited the nuclear translocation of nuclear factor-kappa B induced 
by MG treatment in LLC-PK1 cells. These findings indicate that lipoic acid has potential as a therapeutic 
agent against the development of diabetic complications related to MG-induced oxidative stress in 
diabetes. 
㩷 㩷
㩷 2) Kim H.Y., Jeong D.M., Jung H.J., Jung Y.J., Yokozawa T., and Choi J.S.: Hypolipidemic 
Effects of Sophora flavescens and Its Constituents in Poloxamer 407-Induced 
Hyperlipidemic and Cholesterol-Fed Rats. Biol. Pharm. Bull., 31: 73-78, 2008. 
㩷 Abstract: In this study, we investigated the hypolipidemic effects of Sophora flavescens in poloxamer 
407-induced hyperlipidemic and cholesterol-fed rats. The MeOH extract and 4 fractions of S. flavescens 
were administered at doses of 250 and 100 mg/kg body weight, respectively, once a day for 3 d to the 
poloxamer 407-induced hyperlipidemic rats. Serum lipid levels such as total cholesterol (TC), 
triglycerides (TG), and low-density lipoprotein-cholesterol (LDL-C) were markedly elevated in the 
poloxamer 407-induced hyperlipidemic control rats, while lipid levels were significantly decreased in the 
rats administered the MeOH extract or 4 fractions of S. flavescens. In addition, serum high-density 
lipoprotein-cholesterol (HDL-C) was reduced in the poloxamer 407-induced hyperlipidemic control rats. 
However, oral administration of both the MeOH extract and 4 fractions significantly increased HDL-C 
levels. Of the tested fractions, the EtOAc fraction showed the strongest lipid-lowering effect, as well as a 
high antiatherogenic potential with atherogenic index (A.I.) values of less than 1.92. We also investigated 
the hypolipidemic effects of the main compounds of the EtOAc fraction, kurarinol and kuraridinol, using 
the hyperlipidemic and hypercholesterolemic animal models. Here, elevated TC, TG, and LDL-C levels in 
the poloxamer 407-induced hyperlipidemic and cholesterol-fed rats were significantly reduced after oral 
administration of the compounds, and HDL-C levels had a significant increase. Furthermore, A.I. values 
were lowered by administering kurarinol and kuraridinol. In particular, kuraridinol exhibited stronger 
protective activities against hyperlipidemia than kurarinol. These results suggest that S. flavescens and its 
constituents may be effective cholesterol-lowering agents and useful for preventing hypercholesterolemic 
atherosclerosis.
㩷 㩷
㩷 3) Kang K.S.*, Yamabe N., Kim H.Y., Park J.H., and Yokozawa T.: Therapeutic potential of 
20(S)-ginsenoside Rg3 against streptozotocin-induced diabetic renal damage in rats. Eur. J. 
Pharmacol., 591: 266-272, 2008. 
㩷 Abstract: The inhibitors of advanced glycation endproduct and oxidative stress, as well as 
N-methyl-d-aspartate (NMDA) receptor antagonists have received considerable interest because of their 
close association with renoprotective effects. The therapeutic potential of 20(S)-ginsenoside Rg3
(20(S)-Rg3), isolated from Panax ginseng, against streptozotocin-induced diabetic renal damage, was 
investigated in this study. The diabetic rats received 5, 10, and 20 mg/kg body weight/day of 20(S)-Rg3
orally via gavage for fifteen consecutive days. The physiological abnormalities such as increases in water 
intake and urine volume of diabetic rats were significantly decreased by the 20 mg/kg body weight of 
20(S)-Rg3 administration. The elevated serum glucose, glycosylated protein, and thiobarbituric 
acid-reactive substance levels in diabetic rats were also significantly reduced by the 20(S)-Rg3
administrations. Moreover, the renal dysfunction of diabetic rats was significantly ameliorated by the 
20(S)-Rg3 administrations in a dose-dependent manner. These beneficial effects on diabetic renal damage 
were related to the inhibitory effect of 20(S)-Rg3 against NMDA receptor-mediated nitrosative stress. 
㩷 㩷 㩷
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㩷 4) Kang K.S.*, Yamabe N., Kim H.Y., and Yokozawa T.: Role of maltol in advanced glycation 
end products and free radicals: in-vitro and in-vivo studies. J. Pharm. Pharmacol., 60: 
445-452, 2008. 
㩷 Abstract: Inhibitors of advanced glycation end products (AGEs) have potential as preventive agents 
against diabetic complications. In-vitro AGE inhibitory activity, transition metal chelating, and free 
radical scavenging activity tests have been used to screen for and identify effective AGE inhibitors. In an 
ongoing project to elucidate AGE inhibiting active components of heat-processed ginseng, maltol was 
selected for more detailed investigation. Although there are several lines of evidence concerning the 
antioxidant activity of maltol, the in-vitro and in-vivo inhibitory effects of maltol on AGE generation have 
not been evaluated. In the present study, the in-vitro AGE inhibitory effects and free radical scavenging 
activity of maltol were investigated. In addition, the in-vivo therapeutic potential of maltol against diabetic 
renal damage was tested using streptozotocin (STZ)-diabetic rats. Maltol showed a stronger AGE 
inhibitory effect than aminoguanidine, a well known AGE inhibitor. In addition, the hydroxyl radical 
scavenging activity of maltol on electron spin resonance (ESR) spectrometry was slightly stronger than 
that of aminoguanidine. Therefore, maltol was found to have stronger in-vitro AGE inhibiting activity 
compared with aminoguanidine. The administration of 50 mgkg(-1) per day of maltol suppressed the 
elevated serum levels of glycosylated protein, renal fluorescent AGEs, carboxymethyllysine, receptors for 
AGEs, and nuclear factor-kappaB p65 in diabetic control rats. These beneficial effects of maltol against 
STZ-diabetic renal damage were thought to result from its free radical scavenging and AGE inhibitory 
effects.㩷
㩷 㩷 㩷
㩷 5) Yokozawa T., Kim H.J., and Cho E.J.: Gravinol Ameliorates High-Fructose-Induced 
Metabolic Syndrome through Regulation of Lipid Metabolism and Proinflammatory State in 
Rats. J. Agric. Food Chem., 56: 5026-5032, 2008. 
㩷 Abstract: Using a rat model with fructose-induced metabolic syndrome, the effect of gravinol was 
investigated. Male Wistar rats were fed a 65% fructose diet and administered 10 or 20 mg of gravinol/kg of 
body weight/day for 2 weeks. High-level fructose feeding led to hyperglycemia, hyperlipidemia, 
hypertri-glyceridemia, and hypertension. On the other hand, the administration of gravinol significantly 
lowered serum glucose and total cholesterol levels. The tail arterial blood pressure was significantly 
elevated with the high-fructose diet. However, rats given gravinol showed a lower blood pressure as 
compared with fructose-fed control rats. In addition, the triglyceride (TG) levels in serum and lipoprotein 
fraction were dose-dependently reduced in rats fed gravinol. The decreases of hepatic TG and total 
cholesterol by gravinol were responsible for the down-regulation of hepatic sterol regulatory element 
binding protein (SREBP)-1. However, gravinol did not affect the protein levels of hepatic peroxisome 
proliferator-activated receptor-alpha and SREBP-2. Moreover, gravinol administration in the fructose-fed 
rats markedly reduced the glycosylated protein and thiobarbituric acid-reactive substance levels in the 
serum and hepatic mitochondria, and it inhibited the increase of the cyclooxygenase-2 protein level as a 
result of the down-regulation of nuclear factor kappa B (NF-kappaB). Furthermore, the decrease of 
anti-apoptotic bcl-2 protein levels and the increase of pro-apoptotic bax protein levels by the high-fructose 
diet were reversed by gravinol. These findings suggest that fructose-induced metabolic syndrome is 
attenuated by gravinol administration, which is associated with the reduction of serum lipids and 
protection against the proinflammatory state induced by oxidative stress. 
㩷 㩷 㩷
㩷 6) Kim J.Y., Kim H.S., Kang H.S., Choi J.S., Yokozawa T., and Chung H.Y.: Antioxidant 
Potential of Dimethyl Lithospermate Isolated from Salvia miltiorrhiza (Red Sage) Against 
Peroxynitrite. J. Med. Food, 11: 21-28, 2008. 
㩷 Abstract: Peroxynitrite (ONOO-) is a reactive oxidant formed from superoxide and nitric oxide that can 
readily oxidize cellular components, including essential protein, non-protein thiols, and DNA. ONOO
-
 has 
contributed to the pathogenesis of diseases such as stroke, heart disease, Alzheimer's disease, and 
atherosclerosis. In this study, the ability of dimethyl lithospermate (DML), isolated from Salvia 
miltiorrhiza, to scavenge ONOO- and to protect cells against reactive species and ONOO- was 
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investigated. The data obtained show that DML can efficiently scavenge native ONOO
-
 as well as ONOO
-
derived from the ONOO
-
 donor 3-morpholinosydnonimine hydrochloride. Spectrophotometric analysis 
revealed that DML led to decreased ONOO
-
-mediated nitration of tyrosine through electron donation. 
DML significantly inhibited nitration of bovine serum albumin by ONOO
-
 in a dose-dependent manner. 
DML also manifested cytoprotection from cell damage induced by ONOO
-
. The present study suggests 
that DML is an effective ONOO
-
 scavenger and promotes cellular defense activity in the protection against 
ONOO
-
-involved diseases.㩷
㩷 㩷 㩷
㩷 7) Lee Y.A*, Cho E.J., and Yokozawa T.: Protective Effect of Persimmon (Diospyros Kaki) Peel 
Proanthocyanidin against Oxidative Damage under H2O2-Induced Cellular Senescence. Biol. 
Pharm. Bull., 31: 1265-1269, 2008. 
㩷 Abstract: 8-Hydroxy-2'-deoxyguanosine (8-OHdG), one of the most abundant oxidative DNA adducts, is 
used as an indicator of oxidative DNA damage associated with aging. Among homologs of the silent 
information regulator (Sir), sirtuin 1 (SIRT1) is suggested as a regulator of the apoptotic response to DNA 
damage. Since it has been suggested that the aging process can be delayed by the attenuation of oxidative 
damage such as DNA damage or SIRT1 modulation, we focused on the protective effect against cellular 
oxidative damage of persimmon peel, a proanthocyanidin-rich food, in relation to its level of 
polymerization. We confirmed that 8-OHdG expression in TIG-1 human fibroblasts was increased by 
treatment with 300 microM H2O2 for 2 h. On the other hand, the nuclear SIRT1 level was decreased in 
H2O2-treated as compared with non-pretreated cells. However, pretreatments with polymers and 
oligomers led to a decrease in 8-OHdG and elevation in nuclear SIRT1 expression in a 
concentration-dependent manner. In particular, oligomers exerted a stronger effect. The present study 
supports the protective potential of proanthocyanidin from persimmon peel against oxidative damage 
under the aging process, and suggests that the polymerization of proanthocyanidin plays an important role 
in retarding aging in a cellular senescence model.㩷
㩷 㩷 㩷
㩷 8) Lee Y.A*, Cho E.J., and Yokozawa T.: Effects of Proanthocyanidin Preparations on 
Hyperlipidemia and Other Biomarkers in Mouse Model of Type 2 Diabetes. J. Agric. Food 
Chem., 56: 7781-7789, 2008. 
㩷 Abstract: The protective effect of proanthocyanidins from persimmon peel, using both oligomers and 
polymers, was investigated in a db/db type 2 diabetes model. Male db/db mice were divided into three 
groups: control (vehicle), polymer-, or oligomer- (10 mg/(kg body weight x day x p.o.)) administered 
mice. Age-matched nondiabetic m/m mice were used as a normal group. The administration of 
proanthocyanidins reduced hyperglycemia in db/db mice through a decline in the serum level of glucose 
and glycosylated protein. In addition, it had a strong effect on hyperlipidemia through lowering levels of 
triglyceride, total cholesterol, and nonesterified fatty acids. The protective effect against hyperglycemia 
and hyperlipidemia was greater in the groups administered the oligomeric rather than polymeric form. The 
increased oxidative stress in db/db mice was attenuated by the administration of oligomers through 
inhibiting the generation of reactive oxygen species and lipid peroxidation and elevating the reduced 
glutathione/oxidized glutathione ratio. On the other hand, polymers did not show such an effect. 
Moreover, expressions in the liver of sterol regulatory element binding protein (SREBP)-1 and SREBP-2 
were downregulated by the administration of proanthocyanidins, especially the oligomeric form. 
Oligomers caused a slight elevation in the expression of peroxisome proliferator-activated receptors alpha. 
Furthermore, oligomeric proanthocyanidin regulated the expression of nuclear factor kappaB in db/db 
type 2 diabetes via the activation of inhibitor protein kappaB-alpha. It also attenuated the protein 
expressions of cyclooxygenase-2 and inducible nitric oxide synthase. This suggests that oligomers would 
act as a regulator in inflammatory reactions associated with oxidative stress in type 2 diabetes. The present 
study results suggest that proanthocyanidin administration, especially the oligomeric form, may improve 
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oxidative stress via the regulation of hyperlipidemia than hyperglycemia in type 2 diabetes.㩷
㩷 㩷 㩷
㩷 9) Kim Y.J., Kang K.S., and Yokozawa T.: The anti-melanogenic effect of pycnogenol by its 
anti-oxidative actions. Food Chem. Toxicol., 46: 2466-2471, 2008. 
㩷 Abstract: Pycnogenol is a natural plant extract from pine bark that contains compounds that have 
anti-oxidative, free-radical scavenging properties. In this work, utilizing cultured B16 melanoma cells 
(B16 cells), pycnogenol was investigated for its ability to inhibit tyrosinase activity and melanin 
biosynthesis. We also examined the anti-oxidative power of pycnogenol by measuring its suppressive 
effect against peroxynitrite (ONOO
-
), superoxide (.O2), nitric oxide (NO.), and hydroxyl radical 
(.OH)-scavenging activities using an electron spin resonance spectrometer. Results show that pycnogenol 
had a strong anti-tyrosinase activity and suppressed melanin biosynthesis. Further, our results showed that 
through its anti-oxidative properties, pycnogenol suppressed .O2, NO., ONOO
-
, and .OH in in vitro assays, 
and reactive species, ONOO
-
, .O2, and NO., while up-regulating the reduced glutathione/oxidized 
glutathione ratio in B16 cells. Based on the findings, we propose that pycnogenol exerts anti-melanogenic 
activity via its anti-oxidative actions.㩷
㩷 㩷 㩷
㩷 10) Rhyu D.Y., Kang K.S., Sekiya M., Tanaka T., Park J.C., and Yokozawa T.: Active 
Compounds Isolated from Traditional Chinese Prescription Wen-Pi-Tang Protecting Against 
Peroxynitrite-Induced LLC-PK1 Cell Damage. Am. J. Chin. Med., 36: 761-770, 2008. 
㩷 Abstract: Wen-Pi-Tang, a traditional Chinese prescription, has been widely used for the treatment of 
patients with moderate chronic renal failure in China. Although the protective effect of Wen-Pi-Tang on 
peroxynitrite (ONOO
-
)-induced renal tubular epithelial LLC-PK1 cell damage was elucidated in our 
previous research, the active components of Wen-Pi-Tang have not yet been fully clarified. Therefore in 
the present study, we investigated the active components by using a cellular ONOO
-
generation system. As 
a result, p-coumaric acid, 4-(4'-hydroxylphenyl)-2-butanone 4'-O-glucopyranoside, gallic acid 
3-O-(6'-O-galloyl)-beta-d-glucopyranoside, procyanidin B-1, procyanidin B-3, and (+)-catechin were 
isolated as active compounds inhibiting cellular ONOO
-
 formation and cytotoxicity. In particular, the 
content of (+)-catechin was significantly higher than those of the other compounds, and the (+)-catechin 
structure was located in procyanidins B-1 and B-3. Therefore, the major bioactivity of Wen-Pi-Tang 
against ONOO
-
-induced cytotoxicity in LLC-PK1 cells was thought to be mediated by (+)-catechin. 
Although we cannot disregard the synergetic effect of various components in Wen-Pi-Tang, (+)-catechin 
is a major active compound protecting against ONOO
-
-induced LLC-PK1 cell damage and may be used as 
an index to qualify the ONOO
-
-inhibitory activity of Wen-Pi-Tang extract.㩷
㩷 㩷 㩷
㩷 11) Lee Y.J., Kim H.Y., Kang K.S., Lee J.G., Yokozawa T., and Park J.H.: The chemical and 
hydroxyl radical scavenging activity changes of ginsenoside-Rb1 by heat processing. Bioorg. 
Med. Chem. Lett., 15: 4515-4520, 2008. 
㩷 Abstract㪑 The chemical and hydroxyl radical (*OH) scavenging activity changes of ginsenoside Rb1 (Rb1)
by heat processing were investigated in this study. Rb1 was changed into 20(S)-Rg3, 20(R)-Rg3, Rk1, and 
Rg5 by heat processing through glucosyl elimination and epimerization of carbon-20 by SN1 reaction. The 
glucosyl moiety, separated from Rb1, made Maillard reaction product (MRPs) with glycine. The 
generations of 20(S)-Rg3 and MRPs were related to the increased OH scavenging activity of Rb1 by heat 
processing. 
㩷 㩷 㩷
㩷 12) Cho E.J., Okamoto T., and Yokozawa T.: Therapeutic efficacy of Kangen-karyu against 
H2O2-induced premature senescence. J. Pharm. Pharmacol., 60: 1537-1544, 2008. 
㩷 Abstract: The anti-aging potential of Kangen-karyu extract was investigated using the mechanisms of the 
cellular aging model of stress-induced premature senescence (SIPS) in TIG-1 human fibroblasts. SIPS was 
induced by a sublethal dose of H2O2 and chronic oxidative stress with repeat treatment of low-dose H2O2.
―115―
Reactive oxygen species generation, lipid peroxidation, and senescence-associated beta-galactosidase 
activity were elevated in TIG-1 cells under SIPS induced by H2O2. However, Kangen-karyu extract led to 
significant declines in these parameters, suggesting its role in ameliorating oxidative stress-related aging. 
It was also observed that SIPS due to H2O2 treatment led to the loss of cell viability, whereas 
Kangen-karyu extract improved cell viability by attenuating H2O2-induced oxidative damage. TIG-1 cells 
under the condition of SIPS caused by sublethal and chronic low doses of H2O2 showed nuclear 
factor-kappaB (NF-kappaB) translocation to the nucleus from the cytosol, while Kangen-karyu extract 
inhibited NF-kappaB nuclear translocation, implying that Kangen-karyu extract could exert an anti-aging 
effect through NF-kappaB modulation. In addition, treatment with Kangen-karyu extract under 
H2O2-induced chronic oxidative stress normalized the cell cycle by reducing the number of cells in the 
G0/G1 phase and elevating the proportion of those in the S phase, indicating the role of Kangen-karyu 
extract in cell cycle regulation. On the other hand, Kangen-karyu extract did not exert such an effect on 
cell cycle regulation under acute oxidative stress induced by sublethal H2O2. Furthermore, treatment with 
Kangen-karyu extract prolonged the lifespan of TIG-1 cells under SIPS. The present study suggests that 
Kangen-karyu might play a therapeutic role against the aging process caused by oxidative stress.㩷
㩷 㩷 㩷
㩷 13) Yokozawa T., Yamabe N., Kim H.Y., Kang K.S., Hur J.M., Park C.H., and Tanaka T.: 
Protective Effects of Morroniside Isolated from Corni Fructus against Renal Damage in 
Streptozotocin-Induced Diabetic Rats. Biol. Pharm. Bull., 31: 1422-1428, 2008. 
㩷 Abstract: In our previous study, we reported the renoprotective effect of Hachimi-jio-gan, a Chinese 
traditional prescription consisting of eight medicinal plants, and also reported the effect of Corni Fructus 
(Cornus officinalis SIEB. et ZUCC.), a component of Hachimi-jio-gan, on diabetic nephropathy using 
diabetic rats. In this study, we investigated the effects of morroniside isolated from Corni Fructus on renal 
damage in streptozotocin-treated diabetic rats. Oral administration of morroniside at a dose of 20 or 100 
mg/kg body weight/d for 20 d to diabetic rats resulted in significant decreases in increasing serum glucose 
and urinary protein levels. Moreover, the decreased levels of serum albumin and total protein in diabetic 
rats were significantly increased by morroniside administration at a dose of 100 mg/kg body weight/d. In 
addition, morroniside significantly reduced the elevated serum urea nitrogen level and showed a tendency 
to reduce creatinine clearance. Morroniside also significantly reduced the enhanced levels of serum 
glycosylated protein, and serum and renal thiobarbituric acid-reactive substances. Protein expressions 
related to the advanced glycation endproduct (AGE) level and actions, oxidative stress such as 
N(epsilon)-(carboxyethyl)lysine, as well as receptors for AGE and heme oxygenase-1 were increased in 
diabetic rats, but the levels were also significantly decreased by the administration of morroniside. This 
suggests that morroniside exhibits protective effects against diabetic renal damage by inhibiting 
hyperglycemia and oxidative stress. These results indicate that morroniside is one component partly 
responsible for the protective effects of Corni Fructus and Hachimi-jio-gan against diabetic renal damage.
㩷 㩷 㩷
㩷 14) Kim H.Y., Kang K.S., Yamabe N., and Yokozawa T.: Comparison of the Effects of Korean 
Ginseng and Heat-Processed Korean Ginseng on Diabetic Oxidative Stress. Am. J. Chin. 
Med., 36: 989-1004, 2008. 
㩷 Abstract㪑 To investigate the effects of Korean ginseng (KG, Panax ginseng C.A. Meyer) and 
heat-processed Korean ginseng (H-KG) on diabetic renal damage, we used the streptozotocin-induced 
diabetic rat model in this study. The diabetes-induced physiological abnormalities at early-stage were 
attenuated by KG or H-KG administration through reducing the blood glucose level and improving renal 
function. The oxidative stress-induced increases in serum and renal thiobarbituric acid-reactive substance 
levels were significantly reduced by KG and H-KG administrations. Moreover, the protein expressions 
related to oxidative stress and advanced glycation endproducts were significantly reduced in diabetic rats 
and/or not significantly increased compared to normal rats by KG or H-KG administration. All of these 
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beneficial effects of H-KG in diabetic rats were stronger than those of KG. Therefore, KG and H-KG may 
improve diabetic pathological conditions and prevent renal damage associated with diabetic nephropathy, 
and these protective effects of KG can be improved by heat-processing. This study provides scientific 
evidence that H-KG may be a potential therapeutic agent for pathological conditions associated with 
diabetic complications including diabetic nephropathy. 
㩷
㩷 15) Tohda C., Naito R., and Joyashiki E.: Kihi-to, a herbal traditional medicine, improves 
Aȕ(25-35)-induced memory impairment and losses of neurites and synapses. BMC 
Complementary and Alternative Medicine, 8: 49, 2008. 
㩷 Abstract㪑 Background:  We previously hypothesized that achievement of recovery of brain function after 
the injury requires the reconstruction of neuronal networks, including neurite regeneration and synapse 
reformation. Kihi-to is composed of twelve crude drugs, some of which have already been shown to 
possess neurite extension properties in our previous studies. The effect of Kihi-to on memory deficit has 
not been examined. Thus, the goal of the present study is to determine the in vivo and in vitro effects of 
Kihi-to on memory, neurite growth and synapse reconstruction. 
Methods:  Effects of Kihi-to, a traditional Japanese-Chinese traditional medicine, on memory deficits 
and losses of neurites and synapses were examined using Alzheimer's disease model mice. Improvements 
of Aȕ(25–35)-induced neuritic atrophy by Kihi-to and the mechanism were investigated in cultured 
cortical neurons. 
Results: Administration of Kihi-to for consecutive 3 days resulted in marked improvements of 
Aȕ(25–35)-induced impairments in memory acquisition, memory retention, and object recognition 
memory in mice. Immunohistochemical comparisons suggested that Kihi-to attenuated neuritic, synaptic 
and myelin losses in the cerebral cortex, hippocampus and striatum. Kihi-to also attenuated the calpain 
increase in the cerebral cortex and hippocampus. When Kihi-to was added to cells 4 days after Aȕ(25–35) 
treatment, axonal and dendritic outgrowths in cultured cortical neurons were restored as demonstrated by 
extended lengths of phosphorylated neurofilament-H (P-NF-H) and microtubule-associated protein 
(MAP)2-positive neurites. Aȕ(25–35)-induced cell death in cortical culture was also markedly inhibited 
by Kihi-to. Since NF-H, MAP2 and myelin basic protein (MBP) are substrates of calpain, and calpain is 
known to be involved in Aȕ-induced axonal atrophy, expression levels of calpain and calpastatin were 
measured. Treatment with Kihi-to inhibited the Aȕ(25–35)-evoked increase in the calpain level and 
decrease in the calpastatin level. In addition, Kihi-to inhibited Aȕ(25–35)-induced calcium entry. 
Conclusion:  In conclusion Kihi-to clearly improved the memory impairment and losses of neurites and 
synapses. 
㩷 㩷 㩷
㩷
㩷
16) Tohda C., Ichimura M., Bai Y., Tanaka K., Zhu S., and Komatsu K.: Inhibitory effects of 
Eleutherococcus senticosus extracts on amyloid ȕ(25-35)-induced neuritic atrophy and 
synaptic loss. J. Pharmacol. Sci., 107: 329-339, 2008. 
㩷 Abstract: Neurons with atrophic neurites may remain alive and therefore may have the potential to 
regenerate even when neuronal death has occurred in some parts of the brain. This study aimed to explore 
effects of drugs that can facilitate the regeneration of neurites and the reconstruction of synapses even in 
severely damaged neurons. We investigated the effects of Eleutherococcus senticosus extracts on the 
regeneration of neurites and the reconstruction of synapses in rat cultured cortical neurons damaged by 
amyloid beta (Abeta)(25-35). Treatment with Abeta(25-35) (10 microM) induced axonal and dendritic 
atrophies and synaptic loss in cortical neurons. Subsequent treatment with the methanol extract and the 
water extract of E. senticosus (10 - 1000 ng/ml) resulted in significant axonal and dendritic regenerations 
and reconstruction of neuronal synapses. Co-application of the extract and Abeta(25-35) attenuated 
Abeta(25-35)-induced neuronal death. We investigated neurite outgrowth activities of eleutherosides B 
and E and isoflaxidin, which are known as major compounds in E. senticosus. Although eleutheroside B 
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protected against Abeta(25-35)-induced dendritic and axonal atrophies, the activities of eleutheroside E 
and isofraxidin were less than that of eleutheroside B. Although the contents of these three compounds in 
the water extract were less than in the methanol extract, restoring activities against neuronal damages were 
not different between the two extracts. In conclusion, extracts of E. senticosus protect against neuritic 
atrophy and cell death under Abeta treatment, and one of active constituents may be eleutheroside B.㩷
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